This discovery not only provides a theoretical basis for TRIP6 as a potential therapeutic target in colorectal cancer, but also unveils its potential role as a key bridge linking intrinsic tumor cell characteristics with the external immune microenvironment. The gene discussed is TRIP6; the disease is neoplasm.